Skip to main content

Table 2 High retention rates were evidenced across the trials in KwaZulu-Natal.

From: Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa

Trial

Retention

MIRA

(average at two sites)

94%

Carraguard

97%

CS

92%

HPTN 035

(average at two sites)

95%

MDP 301

(average at three sites)

96%

Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us